This Week in Washington: House and Senate not in session, U.S. reaches debt-ceiling limit



Rep. Frank Pallone Questions FDA and NIH Over Federally Funded Clinical Trial Reporting Compliance

On Jan. 19, Rep. Frank Pallone (D-NJ) sent a letter to the Food and Drug Administration (FDA) and the National Institutes of Health (NIH), raising concerns over whether medical product sponsors are submitting federally funded clinical trial results to the database. Medical products sponsors are required to submit clinical trial results to the federal database, in order to provide healthcare providers and researchers with safety and efficacy information. A recent study revealed that up to 31 percent of clinical trials are going unreported.

Senate not in session.

Read more on healthcare policy in McGuireWoods Consulting’s Washington Healthcare Update.